Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 235 publications
Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
Journal: Nature medicine
Published: July 02, 2024
Immunotherapeutics in nasopharyngeal carcinoma: a relentless CONTINUUM of success.
Journal: Lancet (London, England)
Published: April 09, 2024
Head and neck cancer: high-end technology is no guarantee of high-quality care - Authors' reply.
Journal: Lancet (London, England)
Published: February 15, 2022
Early response dynamics predict treatment failure in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with cetuximab and nivolumab.
Journal: Oral oncology
Published: November 12, 2021
TP53 mutations in head and neck cancer.
Journal: Molecular carcinogenesis
Published: November 12, 2021
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 26, 2021
Application of Artificial Intelligence for Nasopharyngeal Carcinoma Management - A Systematic Review.
Journal: Cancer management and research
Published: September 27, 2021
ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 20, 2021
De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?
Journal: Oral oncology
Published: September 16, 2021
Last Updated: 09/26/2026